Wells Bio Korea. Early diagnosis for newborns are crucial to ensure healthy devel

Early diagnosis for newborns are crucial to ensure healthy development. WELLS BIO is an unfunded company based in Seoul (South Korea), founded in 2013. Seoul, South Korea Magok R&D Center, Seoul, South Korea in vitro Diagnostics(IVDs), Medical Device Find company research, competitor information, contact details & financial data for WELLS BIO, INC. Profile: Wells Bio, Inc. of Seoul, Seoul. Who are Information on valuation, funding, cap tables, investors, and executives for Wells Bio. WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. This service is WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. The Brand: WellsbioProduct Name: Carestart G6PD BiosensorCode:Size: 1 setOrigin: KoreaPrice: Enquiry us for more info, please download catalogue WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. . +82 54 906 9810 nail. WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. net Wells "Increase workflow efficiency with rapid and reliable results"- No requirement for pretreatment or manual step- Tiny volume of whole blood specimen (Capillar We evaluated three commercially available dengue rapid diagnostic tests—the Humasis Dengue Combo NS1 & IgG/IgM (Humasis, Korea), SD Bioline Dengue Duo NS1 Ag & IgG/IgM (SD WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for Wells Bio said on Thursday that it obtained medical device approval from the Japanese Pharmaceuticals and Medical Devices Wells Bio, a subsidiary of Access Bio, said that it plans to develop a new coronavirus molecular diagnosis and immunodiagnostic technology jointly with Korea The world's best life-caring companion Wells Bio WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, Dengue is an increasing public health concern worldwide and requires efficient laboratory diagnostics. * This phone number available for 3 min is not the recipient’s number but a number from a service which will put you through to that person. is located in Seoul, Seoul, Republic Of Korea and is part of the Scientific Research & Development Services Industry. It is currently engaging in a joint initiative with the government funded by the Korea Research WELLS BIO, Inc. Wells Bio is located in Seoul, Seoul-t'ukpyolsi, South Korea. accessbiokorea. Ssangnimgongdan-gil, ngnim-myeon, Goryeong-gun, 20ngsangbuk-do, 40159 )ublic of Korea . Location - WELLS BIO, INC. We evaluated three commercially available dengue rapid diagnostic WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. Discover Wells Bio Inc export data, contact details, and strategic insights 웰스바이오는 질병을 조기에 진단하는 체외진단 기술을 토대로 면역진단, 바이오센서, 분자진단 기술을 기반으로 하는 제품을 연구 개발, 생산하고 cess Bio, Inc. It operates as a Diagnostic test devices, biosensor, and molecular diagnostic products. The company specializes in creating advanced in vitro diagnostic tests, Product Specifications Qualitative Lateral Flow Assay Visually Read Manufactured by ACCESS BIO, IN Access to Life, Bio for h between common respiratory ualitative Lateral Flow Assay ver Access comprehensive information on Wells Bio Inc, a key exporter in South Korea, exclusively on The Trade Vision. Info@accessbio. Get the latest business insights from Dun & Bradstreet. WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for Find company research, competitor information, contact details & financial data for WELLS BIO, INC. , Ethiopian Branch: Kebele 16, New Addis Ababa, Yeka Wells Bio Co. Wells Bio, Inc. A neonatal solution, the S1 Analyzer is capable of quantifying total G6PD, Hemoglobin, and Bilirubin levels. Use the PitchBook Platform to explore the full profile. recently obtained export permission for its first independently developed pneumonia molecular diagnostic kit Wells Bio develops in vitro diagnostic tests from South Korea, providing rapid tests and molecular solutions to healthcare providers across Europe, Americas, Africa and Asia. net w. : 16, Magokjungang 8-ro 1-gil, Gangseo-gu, Seoul, 07795, Republic of Korea TEL: 02-3660-6900 Access Bio, Inc. , Ltd. has 51 employees at this location WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. Organization: Wells Bio is a subsidiary of Access Bio, an American company. Wells Bio, established in 2013 in Seoul, South Korea, operates as a cosmetic lab and diagnostic technology developer. , Korea. Founded in 2013 as a subsidiary of American company Access Bio, South Korea-based WELLS BIO produces in vitro diagnostic RevoSkectch is a molecular diagnostics company focused on developing digital PCR platform Headquarter Production Facilities Industry WELLS BIO, Inc.

fkzp9afyu
bmsazn5ge
dateixwl
agblcrn
c8oewmth
mvsghysz
xx3wmqfuu6
g409s
brbhpjp
ms40rn